{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:48:45Z","timestamp":1790232525102,"version":"4.1.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s11427-017-9176-7","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T13:46:53Z","timestamp":1507816013000},"page":"1058-1064","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The role of T-cell immunoglobulin mucin-3 and its ligand galectin-9 in antitumor immunity and cancer immunotherapy"],"prefix":"10.1007","volume":"60","author":[{"given":"Riyao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mien-Chie","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,11]]},"reference":[{"key":"9176_CR1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nature21508","volume":"543","author":"R.A. Amezquita","year":"2017","unstructured":"Amezquita, R.A., and Kaech, S.M. (2017). Immunology: The chronicles of T-cell exhaustion. Nature 543, 190\u2013191.","journal-title":"Nature"},{"key":"9176_CR2","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/ijc.30159","volume":"139","author":"L. Andzinski","year":"2016","unstructured":"Andzinski, L., Spanier, J., Kasnitz, N., Kr\u00f6ger, A., Jin, L., Brinkmann, M.M., Kalinke, U., Weiss, S., Jablonska, J., and Lienenklaus, S. (2016). Growing tumors induce a local STING dependent Type I IFN response in dendritic cells. Int J Cancer 139, 1350\u20131357.","journal-title":"Int J Cancer"},{"key":"9176_CR3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1146\/annurev-immunol-032414-112049","volume":"34","author":"S.H. Baumeister","year":"2016","unstructured":"Baumeister, S.H., Freeman, G.J., Dranoff, G., and Sharpe, A.H. (2016). Coinhibitory pathways in immunotherapy for cancer. Annu Rev Immunol 34, 539\u2013573.","journal-title":"Annu Rev Immunol"},{"key":"9176_CR4","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","volume":"167","author":"J.L. Benci","year":"2016","unstructured":"Benci, J.L., Xu, B., Qiu, Y., Wu, T.J., Dada, H., Twyman-Saint Victor, C., Cucolo, L., Lee, D.S.M., Pauken, K.E., Huang, A.C., Gangadhar, T.C., Amaravadi, R.K., Schuchter, L.M., Feldman, M.D., Ishwaran, H., Vonderheide, R.H., Maity, A., Wherry, E.J., and Minn, A.J. (2016). Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade. Cell 167, 1540\u20131554.","journal-title":"Cell"},{"key":"9176_CR5","doi-asserted-by":"crossref","first-page":"e0124802","DOI":"10.1371\/journal.pone.0124802","volume":"10","author":"N. Boivin","year":"2015","unstructured":"Boivin, N., Baillargeon, J., Do\u00dfs, P.M.I.A., Roy, A.P., and Rangachari, M. (2015). Interferon-\u00df suppresses murine Th1 cell function in the absence of antigen-presenting cells. PLoS ONE 10, e0124802.","journal-title":"PLoS ONE"},{"key":"9176_CR6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ceb.2011.05.001","volume":"23","author":"C. Boscher","year":"2011","unstructured":"Boscher, C., Dennis, J.W., and Nabi, I.R. (2011). Glycosylation, galectins and cellular signaling. Curr Opin Cell Biol 23, 383\u2013392.","journal-title":"Curr Opin Cell Biol"},{"key":"9176_CR7","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.4049\/jimmunol.1001734","volume":"185","author":"N. Boucheron","year":"2010","unstructured":"Boucheron, N., Sharif, O., Schebesta, A., Croxford, A., Raberger, J., Schmidt, U., Vigl, B., Bauer, J., Bankoti, R., Lassmann, H., Epstein, M.M., Knapp, S., Waisman, A., and Ellmeier, W. (2010). The protein tyrosine kinase Tec regulates a CD44highCD62L-Th17 subset. J Immunol 185, 5111\u20135119.","journal-title":"J Immunol"},{"key":"9176_CR8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.immuni.2007.01.016","volume":"26","author":"E. Cao","year":"2007","unstructured":"Cao, E., Zang, X., Ramagopal, U.A., Mukhopadhaya, A., Fedorov, A., Fedorov, E., Zencheck, W.D., Lary, J.W., Cole, J.L., Deng, H., Xiao, H., Dilorenzo, T.P., Allison, J.P., Nathenson, S.G., and Almo, S.C. (2007). T cell immunoglobulin Mucin-3 crystal structure reveals a Galectin-9-independent ligand-binding surface. Immunity 26, 311\u2013321.","journal-title":"Immunity"},{"key":"9176_CR9","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/ni.2376","volume":"13","author":"S. Chiba","year":"2012","unstructured":"Chiba, S., Baghdadi, M., Akiba, H., Yoshiyama, H., Kinoshita, I., Dosaka-Akita, H., Fujioka, Y., Ohba, Y., Gorman, J.V., Colgan, J.D., Hirashima, M., Uede, T., Takaoka, A., Yagita, H., and Jinushi, M. (2012). Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol 13, 832\u2013842.","journal-title":"Nat Immunol"},{"key":"9176_CR10","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/eji.200839177","volume":"39","author":"F.C. Chou","year":"2009","unstructured":"Chou, F.C., Shieh, S.J., and Sytwu, H.K. (2009). Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice. Eur J Immunol 39, 2403\u20132411.","journal-title":"Eur J Immunol"},{"key":"9176_CR11","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4049\/jimmunol.1302663","volume":"192","author":"K.L. Clayton","year":"2014","unstructured":"Clayton, K.L., Haaland, M.S., Douglas-Vail, M.B., Mujib, S., Chew, G.M., Ndhlovu, L.C., and Ostrowski, M.A. (2014). T cell Ig and Mucin domain-containing protein 3 is recruited to the immune synapse, disrupts stable synapse formation, and associates with receptor phosphatases. J Immunol 192, 782\u2013791.","journal-title":"J Immunol"},{"key":"9176_CR12","doi-asserted-by":"crossref","first-page":"9010","DOI":"10.1073\/pnas.0901329106","volume":"106","author":"R.J. Critchley-Thorne","year":"2009","unstructured":"Critchley-Thorne, R.J., Simons, D.L., Yan, N., Miyahira, A.K., Dirbas, F.M., Johnson, D.L., Swetter, S.M., Carlson, R.W., Fisher, G.A., Koong, A., Holmes, S., and Lee, P.P. (2009). Impaired interferon signaling is a common immune defect in human cancer. Proc Natl Acad Sci USA 106, 9010\u20139015.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9176_CR13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nm.4314","volume":"23","author":"D. Daley","year":"2017","unstructured":"Daley, D., Mani, V.R., Mohan, N., Akkad, N., Ochi, A., Heindel, D.W., Lee, K.B., Zambirinis, C.P., Pandian, G.S., Savadkar, S., Torres-Hernandez, A., Nayak, S., Wang, D., Hundeyin, M., Diskin, B., Aykut, B., Werba, G., Barilla, R.M., Rodriguez, R., Chang, S., Gardner, L., Mahal, L.K., Ueberheide, B., and Miller, G. (2017). Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med 23, 556\u2013567.","journal-title":"Nat Med"},{"key":"9176_CR14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/imr.12520","volume":"276","author":"M. Das","year":"2017","unstructured":"Das, M., Zhu, C., and Kuchroo, V.K. (2017). Tim-3 and its role in regulating anti-tumor immunity. Immunol Rev 276, 97\u2013111.","journal-title":"Immunol Rev"},{"key":"9176_CR15","first-page":"1918","volume":"184","author":"R.H. DeKruyff","year":"2010","unstructured":"DeKruyff, R.H., Bu, X., Ballesteros, A., Santiago, C., Chim, Y.L.E., Lee, H.H., Karisola, P., Pichavant, M., Kaplan, G.G., Umetsu, D.T., Freeman, G.J., and Casasnovas, J.M. (2010). T cell\/transmembrane, Ig, and Mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells. JI 184, 1918\u20131930.","journal-title":"JI"},{"key":"9176_CR16","doi-asserted-by":"crossref","first-page":"E645","DOI":"10.3390\/ijms18030645","volume":"18","author":"W. Du","year":"2017","unstructured":"Du, W., Yang, M., Turner, A., Xu, C., Ferris, R.L., Huang, J., Kane, L.P., and Lu, B. (2017). TIM-3 as a target for cancer immunotherapy and mechanisms of action. Int J Mol Sci 18, pii: E645.","journal-title":"Int J Mol Sci"},{"key":"9176_CR17","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","volume":"3","author":"G.P. Dunn","year":"2002","unstructured":"Dunn, G.P., Bruce, A.T., Ikeda, H., Old, L.J., and Schreiber, R.D. (2002). Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3, 991\u2013998.","journal-title":"Nat Immunol"},{"key":"9176_CR18","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ni1213","volume":"6","author":"G.P. Dunn","year":"2005","unstructured":"Dunn, G.P., Bruce, A.T., Sheehan, K.C.F., Shankaran, V., Uppaluri, R., Bui, J.D., Diamond, M.S., Koebel, C.M., Arthur, C., White, J.M., and Schreiber, R.D. (2005). A critical function for type I interferons in cancer immunoediting. Nat Immunol 6, 722\u2013729.","journal-title":"Nat Immunol"},{"key":"9176_CR19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.0105-2896.2010.00903.x","volume":"235","author":"G.J. Freeman","year":"2010","unstructured":"Freeman, G.J., Casasnovas, J.M., Umetsu, D.T., and DeKruyff, R.H. (2010). TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunological Rev 235, 172\u2013189.","journal-title":"Immunological Rev"},{"key":"9176_CR20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.it.2012.10.004","volume":"34","author":"M.B. Fuertes","year":"2013","unstructured":"Fuertes, M.B., Woo, S.R., Burnett, B., Fu, Y.X., and Gajewski, T.F. (2013). Type I interferon response and innate immune sensing of cancer. Trends Immunol 34, 67\u201373.","journal-title":"Trends Immunol"},{"key":"9176_CR21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","volume":"167","author":"J. Gao","year":"2016","unstructured":"Gao, J., Shi, L.Z., Zhao, H., Chen, J., Xiong, L., He, Q., Chen, T., Roszik, J., Bernatchez, C., Woodman, S.E., Chen, P.L., Hwu, P., Allison, J.P., Futreal, A., Wargo, J.A., and Sharma, P. (2016). Loss of IFN-\u03b3 pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy. Cell 167, 397\u2013404.e9.","journal-title":"Cell"},{"key":"9176_CR22","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/eji.201343335","volume":"43","author":"F. Gieseke","year":"2013","unstructured":"Gieseke, F., Kruchen, A., Tzaribachev, N., Bentzien, F., Dominici, M., and M\u00fcller, I. (2013). Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferation. Eur J Immunol 43, 2741\u20132749.","journal-title":"Eur J Immunol"},{"key":"9176_CR23","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.4049\/jimmunol.1004043","volume":"186","author":"H. Guan","year":"2011","unstructured":"Guan, H., Nagarkatti, P.S., and Nagarkatti, M. (2011). CD44 reciprocally regulates the differentiation of encephalitogenic Th1\/Th17 and Th2\/regulatory T cells through epigenetic modulation involving DNA methylation of cytokine gene promoters, thereby controlling the development of experimental autoimmune encephalomyelitis. J Immunol 186, 6955\u20136964.","journal-title":"J Immunol"},{"key":"9176_CR24","doi-asserted-by":"crossref","first-page":"14733","DOI":"10.1073\/pnas.1009731107","volume":"107","author":"H.T. Jin","year":"2010","unstructured":"Jin, H.T., Anderson, A.C., Tan, W.G., West, E.E., Ha, S.J., Araki, K., Freeman, G.J., Kuchroo, V.K., and Ahmed, R. (2010). Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci USA 107, 14733\u201314738.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9176_CR25","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1073\/pnas.95.13.7556","volume":"95","author":"D.H. Kaplan","year":"1998","unstructured":"Kaplan, D.H., Shankaran, V., Dighe, A.S., Stockert, E., Aguet, M., Old, L.J., and Schreiber, R.D. (1998). Demonstration of an interferon-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA 95, 7556\u20137561.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9176_CR26","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.4049\/jimmunol.170.7.3631","volume":"170","author":"Y. Kashio","year":"2003","unstructured":"Kashio, Y., Nakamura, K., Abedin, M.J., Seki, M., Nishi, N., Yoshida, N., Nakamura, T., and Hirashima, M. (2003). Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J Immunol 170, 3631\u20133636.","journal-title":"J Immunol"},{"key":"9176_CR27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ccell.2017.01.004","volume":"31","author":"K.V. Katlinski","year":"2017","unstructured":"Katlinski, K.V., Gui, J., Katlinskaya, Y.V., Ortiz, A., Chakraborty, R., Bhattacharya, S., Carbone, C.J., Beiting, D.P., Girondo, M.A., Peck, A.R., Pur\u00e9, E., Chatterji, P., Rustgi, A.K., Diehl, J.A., Koumenis, C., Rui, H., and Fuchs, S.Y. (2017). Inactivation of interferon receptor promotes the establishment of immune privileged tumor microenvironment. Cancer Cell 31, 194\u2013207.","journal-title":"Cancer Cell"},{"key":"9176_CR28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/1471-2407-6-283","volume":"6","author":"C. Keryer-Bibens","year":"2006","unstructured":"Keryer-Bibens, C., Pioche-Durieu, C., Villemant, C., Souqu\u00e8re, S., Nishi, N., Hirashima, M., Middeldorp, J., and Busson, P. (2006). Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral Latent Membrane Protein 1 and the immunomodulatory protein galectin 9. BMC Cancer 6, 283.","journal-title":"BMC Cancer"},{"key":"9176_CR29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.stem.2015.07.011","volume":"17","author":"Y. Kikushige","year":"2015","unstructured":"Kikushige, Y., Miyamoto, T., Yuda, J., Jabbarzadeh-Tabrizi, S., Shima, T., Takayanagi, S., Niiro, H., Yurino, A., Miyawaki, K., Takenaka, K., Iwasaki, H., and Akashi, K. (2015). A TIM-3\/Gal-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemic progression. Cell Stem Cell 17, 341\u2013352.","journal-title":"Cell Stem Cell"},{"key":"9176_CR30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4110\/in.2015.15.5.241","volume":"15","author":"S.N. Kim","year":"2015","unstructured":"Kim, S.N., Lee, H.J., Jeon, M.S., Yi, T.G., and Song, S.U. (2015). Galectin-9 is involved in immunosuppression mediated by human bone marrowderived clonal mesenchymal stem cells. Immune Netw 15, 241\u2013251.","journal-title":"Immune Netw"},{"key":"9176_CR31","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.cell.2015.08.052","volume":"162","author":"S. Kleffel","year":"2015","unstructured":"Kleffel, S., Posch, C., Barthel, S.R., Mueller, H., Schlapbach, C., Guenova, E., Elco, C.P., Lee, N., Juneja, V.R., Zhan, Q., Lian, C.G., Thomi, R., Hoetzenecker, W., Cozzio, A., Dummer, R., Mihm Jr., M.C., Flaherty, K.T., Frank, M.H., Murphy, G.F., Sharpe, A.H., Kupper, T.S., and Schatton, T. (2015). Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth. Cell 162, 1242\u20131256.","journal-title":"Cell"},{"key":"9176_CR32","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1182\/blood-2008-02-142596","volume":"113","author":"J. Klibi","year":"2009","unstructured":"Klibi, J., Niki, T., Riedel, A., Pioche-Durieu, C., Souquere, S., Rubinstein, E., Le Moulec, S., Moulec, S.L.E., Guigay, J., Hirashima, M., Guemira, F., Adhikary, D., Mautner, J., and Busson, P. (2009). Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood 113, 1957\u20131966.","journal-title":"Blood"},{"key":"9176_CR33","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood-2009-12-255125","volume":"116","author":"A. Kondo","year":"2010","unstructured":"Kondo, A., Yamashita, T., Tamura, H., Zhao, W., Tsuji, T., Shimizu, M., Shinya, E., Takahashi, H., Tamada, K., Chen, L., Dan, K., and Ogata, K. (2010). Interferon-gamma and tumor necrosis factor-alpha induce an immunoinhibitory molecule, B7-H1, via nuclear factor-kappaB activation in blasts in myelodysplastic syndromes. Blood 116, 1124\u20131131.","journal-title":"Blood"},{"key":"9176_CR34","doi-asserted-by":"crossref","first-page":"10501","DOI":"10.1038\/ncomms10501","volume":"7","author":"S. Koyama","year":"2016","unstructured":"Koyama, S., Akbay, E.A., Li, Y.Y., Herter-Sprie, G.S., Buczkowski, K.A., Richards, W.G., Gandhi, L., Redig, A.J., Rodig, S.J., Asahina, H., Jones, R.E., Kulkarni, M.M., Kuraguchi, M., Palakurthi, S., Fecci, P.E., Johnson, B.E., Janne, P.A., Engelman, J.A., Gangadharan, S.P., Costa, D.B., Freeman, G.J., Bueno, R., Hodi, F.S., Dranoff, G., Wong, K.K., and Hammerman, P.S. (2016). Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints. Nat Commun 7, 10501.","journal-title":"Nat Commun"},{"key":"9176_CR35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","volume":"373","author":"J. Larkin","year":"2015","unstructured":"Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J.J., Cowey, C.L., Lao, C.D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., Ferrucci, P.F., Hill, A., Wagstaff, J., Carlino, M.S., Haanen, J.B., Maio, M., Marquez-Rodas, I., McArthur, G.A., Ascierto, P.A., Long, G.V., Callahan, M.K., Postow, M.A., Grossmann, K., Sznol, M., Dreno, B., Bastholt, L., Yang, A., Rollin, L.M., Horak, C., Hodi, F.S., and Wolchok, J.D. (2015). Combined Nivolumab and Ipilimumab or monotherapy in untreated melanoma. N Engl J Med 373, 23\u201334.","journal-title":"N Engl J Med"},{"key":"9176_CR36","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1128\/MCB.05297-11","volume":"31","author":"J. Lee","year":"2011","unstructured":"Lee, J., Su, E.W., Zhu, C., Hainline, S., Phuah, J., Moroco, J.A., Smithgall, T.E., Kuchroo, V.K., and Kane, L.P. (2011). Phosphotyrosine-dependent coupling of Tim-3 to T-cell receptor signaling pathways. Mol Cellular Biol 31, 3963\u20133974.","journal-title":"Mol Cellular Biol"},{"key":"9176_CR37","doi-asserted-by":"crossref","first-page":"12632","DOI":"10.1038\/ncomms12632","volume":"7","author":"C.W. Li","year":"2016","unstructured":"Li, C.W., Lim, S.O., Xia, W., Lee, H.H., Chan, L.C., Kuo, C.W., Khoo, K.H., Chang, S.S., Cha, J.H., Kim, T., Hsu, J.L., Wu, Y., Hsu, J.M., Yamaguchi, H., Ding, Q., Wang, Y., Yao, J., Lee, C.C., Wu, H.J., Sahin, A.A., Allison, J.P., Yu, D., Hortobagyi, G.N., and Hung, M.C. (2016a). Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. Nat Commun 7, 12632.","journal-title":"Nat Commun"},{"key":"9176_CR38","doi-asserted-by":"crossref","first-page":"e1200778","DOI":"10.1080\/2162402X.2016.1200778","volume":"5","author":"J. Li","year":"2016","unstructured":"Li, J., Shayan, G., Avery, L., Jie, H.B., Gildener-Leapman, N., Schmitt, N., Lu, B.F., Kane, L.P., and Ferris, R.L. (2016b). Tumor-infiltrating Tim-3(+) T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk. Oncoimmunology 5, e1200778.","journal-title":"Oncoimmunology"},{"key":"9176_CR39","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ccell.2016.10.010","volume":"30","author":"S.O. Lim","year":"2016","unstructured":"Lim, S.O., Li, C.W., Xia, W., Cha, J.H., Chan, L.C., Wu, Y., Chang, S.S., Lin, W.C., Hsu, J.M., Hsu, Y.H., Kim, T., Chang, W.C., Hsu, J.L., Yamaguchi, H., Ding, Q., Wang, Y., Yang, Y., Chen, C.H., Sahin, A.A., Yu, D., Hortobagyi, G.N., and Hung, M.C. (2016). Deubiquitination and stabilization of PD-L1 by CSN5. Cancer Cell 30, 925\u2013939.","journal-title":"Cancer Cell"},{"key":"9176_CR40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrc1527","volume":"5","author":"F.T. Liu","year":"2005","unstructured":"Liu, F.T., and Rabinovich, G.A. (2005). Galectins as modulators of tumour progression. Nat Rev Cancer 5, 29\u201341.","journal-title":"Nat Rev Cancer"},{"key":"9176_CR41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3892\/mmr.2012.1125","volume":"7","author":"K. Lv","year":"2013","unstructured":"Lv, K., Zhang, Y., Zhang, M., Zhong, M., and Suo, Q. (2013). Galectin-9 promotes TGF-\u00df1-dependent induction of regulatory T cells via the TGF- \u00df\/Smad signaling pathway. Mol Med Rep 7, 205\u2013210.","journal-title":"Mol Med Rep"},{"key":"9176_CR42","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cell.2016.03.031","volume":"165","author":"A.J. Minn","year":"2016","unstructured":"Minn, A.J., and Wherry, E.J. (2016). Combination cancer therapies with immune checkpoint blockade: convergence on interferon signaling. Cell 165, 272\u2013275.","journal-title":"Cell"},{"key":"9176_CR43","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/415536a","volume":"415","author":"L. Monney","year":"2002","unstructured":"Monney, L., Sabatos, C.A., Gaglia, J.L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E.A., Coyle, A.J., Sobel, R.A., Freeman, G.J., and Kuchroo, V.K. (2002). Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415, 536\u2013541.","journal-title":"Nature"},{"key":"9176_CR44","doi-asserted-by":"crossref","first-page":"e60807","DOI":"10.1371\/journal.pone.0060807","volume":"8","author":"M. Moritoki","year":"2013","unstructured":"Moritoki, M., Kadowaki, T., Niki, T., Nakano, D., Soma, G., Mori, H., Kobara, H., Masaki, T., Kohno, M., and Hirashima, M. (2013). Galectin-9 ameliorates clinical severity of MRL\/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3. PLoS ONE 8, e60807.","journal-title":"PLoS ONE"},{"key":"9176_CR45","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.4049\/jimmunol.1102609","volume":"188","author":"S. Mujib","year":"2012","unstructured":"Mujib, S., Jones, R.B., Lo, C., Aidarus, N., Clayton, K., Sakhdari, A., Benko, E., Kovacs, C., and Ostrowski, M.A. (2012). Antigen-independent induction of Tim-3 expression on human T cells by the common?-chain cytokines IL-2, IL-7, IL-15, and IL-21 is associated with proliferation and is dependent on the phosphoinositide 3-kinase pathway. J Immunol 188, 3745\u20133756.","journal-title":"J Immunol"},{"key":"9176_CR46","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","volume":"264","author":"U. Muller","year":"1994","unstructured":"Muller, U., Steinhoff, U., Reis, L.F.L., Hemmi, S., Pavlovic, J., Zinkernagel, R.M., and Aguet, M. (1994). Functional role of type I and type II interferons in antiviral defense. Science 264, 1918\u20131921.","journal-title":"Science"},{"key":"9176_CR47","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1182\/blood-2008-10-185884","volume":"113","author":"M. Nakayama","year":"2009","unstructured":"Nakayama, M., Akiba, H., Takeda, K., Kojima, Y., Hashiguchi, M., Azuma, M., Yagita, H., and Okumura, K. (2009). Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood 113, 3821\u20133830.","journal-title":"Blood"},{"key":"9176_CR48","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.chom.2015.04.005","volume":"17","author":"C.T. Ng","year":"2015","unstructured":"Ng, C.T., Sullivan, B.M., Teijaro, J.R., Lee, A.M., Welch, M., Rice, S., Sheehan, K.C.F., Schreiber, R.D., and Oldstone, M.B.A. (2015). Blockade of interferon beta, but not interferon alpha, signaling controls persistent viral infection. Cell Host Microbe 17, 653\u2013661.","journal-title":"Cell Host Microbe"},{"key":"9176_CR49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2017.06.016","volume":"170","author":"C.J. Nirschl","year":"2017","unstructured":"Nirschl, C.J., Su\u00e1rez-Fari\u00f1as, M., Izar, B., Prakadan, S., Dannenfelser, R., Tirosh, I., Liu, Y., Zhu, Q., Devi, K.S.P., Carroll, S.L., Chau, D., Rezaee, M., Kim, T.G., Huang, R., Fuentes-Duculan, J., Song-Zhao, G.X., Gulati, N., Lowes, M.A., King, S.L., Quintana, F.J., Lee, Y.S., Krueger, J.G., Sarin, K.Y., Yoon, C.H., Garraway, L., Regev, A., Shalek, A.K., Troyanskaya, O., and Anandasabapathy, N. (2017). IFN\u03b3-dependent tissue-immune homeostasis is co-opted in the tumor microenvironment. Cell 170, 127\u2013141.e15.","journal-title":"Cell"},{"key":"9176_CR50","doi-asserted-by":"crossref","first-page":"e48574","DOI":"10.1371\/journal.pone.0048574","volume":"7","author":"S. Oomizu","year":"2012","unstructured":"Oomizu, S., Arikawa, T., Niki, T., Kadowaki, T., Ueno, M., Nishi, N., Yamauchi, A., Hattori, T., Masaki, T., and Hirashima, M. (2012a). Cell surface Galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by Galectin-9 secretion. PLoS ONE 7, e48574.","journal-title":"PLoS ONE"},{"key":"9176_CR51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.clim.2012.01.004","volume":"143","author":"S. Oomizu","year":"2012","unstructured":"Oomizu, S., Arikawa, T., Niki, T., Kadowaki, T., Ueno, M., Nishi, N., Yamauchi, A., and Hirashima, M. (2012b). Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. Clinical Immunol 143, 51\u201358.","journal-title":"Clinical Immunol"},{"key":"9176_CR52","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"D.M. Pardoll","year":"2012","unstructured":"Pardoll, D.M. (2012). The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12, 252\u2013264.","journal-title":"Nat Rev Cancer"},{"key":"9176_CR53","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrc.2016.14","volume":"16","author":"B.S. Parker","year":"2016","unstructured":"Parker, B.S., Rautela, J., and Hertzog, P.J. (2016). Antitumour actions of interferons: implications for cancer therapy. Nat Rev Cancer 16, 131\u2013144.","journal-title":"Nat Rev Cancer"},{"key":"9176_CR54","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.immuni.2016.06.001","volume":"44","author":"J.M. Pitt","year":"2016","unstructured":"Pitt, J.M., V\u00e9tizou, M., Daill\u00e8re, R., Roberti, M.P., Yamazaki, T., Routy, B., Lepage, P., Boneca, I.G., Chamaillard, M., Kroemer, G., and Zitvogel, L. (2016). Resistance mechanisms to immune-checkpoint blockade in cancer: tumor-intrinsic and -extrinsic factors. Immunity 44, 1255\u20131269.","journal-title":"Immunity"},{"key":"9176_CR55","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/nm.2871","volume":"18","author":"M. Rangachari","year":"2012","unstructured":"Rangachari, M., Zhu, C., Sakuishi, K., Xiao, S., Karman, J., Chen, A., Angin, M., Wakeham, A., Greenfield, E.A., Sobel, R.A., Okada, H., McKinnon, P.J., Mak, T.W., Addo, M.M., Anderson, A.C., and Kuchroo, V.K. (2012). Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion. Nat Med 18, 1394\u20131400.","journal-title":"Nat Med"},{"key":"9176_CR56","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni988","volume":"4","author":"C.A. Sabatos","year":"2003","unstructured":"Sabatos, C.A., Chakravarti, S., Cha, E., Schubart, A., S\u00e1nchez-Fueyo, A., Zheng, X.X., Coyle, A.J., Strom, T.B., Freeman, G.J., and Kuchroo, V.K. (2003). Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol 4, 1102\u20131110.","journal-title":"Nat Immunol"},{"key":"9176_CR57","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"R.D. Schreiber","year":"2011","unstructured":"Schreiber, R.D., Old, L.J., and Smyth, M.J. (2011). Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion. Science 331, 1565\u20131570.","journal-title":"Science"},{"key":"9176_CR58","doi-asserted-by":"crossref","first-page":"e1000882","DOI":"10.1371\/journal.ppat.1000882","volume":"6","author":"S. Sehrawat","year":"2010","unstructured":"Sehrawat, S., Reddy, P.B.J., Rajasagi, N., Suryawanshi, A., Hirashima, M., and Rouse, B.T. (2010). Galectin-9\/TIM-3 interaction regulates virusspecific primary and memory CD8+ T cell response. PLoS Pathog 6, e1000882.","journal-title":"PLoS Pathog"},{"key":"9176_CR59","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clim.2008.01.006","volume":"127","author":"M. Seki","year":"2008","unstructured":"Seki, M., Oomizu, S., Sakata, K.M., Sakata, A., Arikawa, T., Watanabe, K., Ito, K., Takeshita, K., Niki, T., Saita, N., Nishi, N., Yamauchi, A., Katoh, S., Matsukawa, A., Kuchroo, V., and Hirashima, M. (2008). Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clinical Immunol 127, 78\u201388.","journal-title":"Clinical Immunol"},{"key":"9176_CR60","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/35074122","volume":"410","author":"V. Shankaran","year":"2001","unstructured":"Shankaran, V., Ikeda, H., Bruce, A.T., White, J.M., Swanson, P.E., Old, L.J., and Schreiber, R.D. (2001). IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.. Nature 410, 1107\u20131111.","journal-title":"Nature"},{"key":"9176_CR61","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P. Sharma","year":"2017","unstructured":"Sharma, P., Hu-Lieskovan, S., Wargo, J.A., and Ribas, A. (2017). Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168, 707\u2013723.","journal-title":"Cell"},{"key":"9176_CR62","doi-asserted-by":"crossref","first-page":"19001","DOI":"10.1073\/pnas.1107087108","volume":"108","author":"S. Sharma","year":"2011","unstructured":"Sharma, S., Sundararajan, A., Suryawanshi, A., Kumar, N., Veiga-Parga, T., Kuchroo, V.K., Thomas, P.G., Sangster, M.Y., and Rouse, B.T. (2011). T cell immunoglobulin and mucin protein-3 (Tim-3)\/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses. Proc Natl Acad Sci USA 108, 19001\u201319006.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9176_CR63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imr.12531","volume":"276","author":"A.H. Sharpe","year":"2017","unstructured":"Sharpe, A.H. (2017). Introduction to checkpoint inhibitors and cancer immunotherapy. Immunol Rev 276, 5\u20138.","journal-title":"Immunol Rev"},{"key":"9176_CR64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd.2016.193","volume":"16","author":"Y. Shi","year":"2017","unstructured":"Shi, Y., Du, L., Lin, L., and Wang, Y. (2017). Tumour-associated mesenchymal stem\/stromal cells: emerging therapeutic targets. Nat Rev Drug Discov 16, 35\u201352.","journal-title":"Nat Rev Drug Discov"},{"key":"9176_CR65","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","volume":"7","author":"D.S. Shin","year":"2017","unstructured":"Shin, D.S., Zaretsky, J.M., Escuin-Ordinas, H., Garcia-Diaz, A., Hu-Lieskovan, S., Kalbasi, A., Grasso, C.S., Hugo, W., Sandoval, S., Torrejon, D.Y., Palaskas, N., Rodriguez, G.A., Parisi, G., Azhdam, A., Chmielowski, B., Cherry, G., Seja, E., Berent-Maoz, B., Shintaku, I.P., Le, D.T., Pardoll, D.M., Diaz Jr, L.A., Tumeh, P.C., Graeber, T.G., Lo, R.S., Comin-Anduix, B., and Ribas, A. (2017). Primary resistance to PD-1 blockade mediated byJAK1\/2 mutations. Cancer Discov 7, 188\u2013201.","journal-title":"Cancer Discov"},{"key":"9176_CR66","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/ni.2396","volume":"13","author":"D. Tang","year":"2012","unstructured":"Tang, D., and Lotze, M.T. (2012). Tumor immunity times out: TIM-3 and HMGB1. Nat Immunol 13, 808\u2013810.","journal-title":"Nat Immunol"},{"key":"9176_CR67","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-immunol-041015-055402","volume":"34","author":"S. Thiemann","year":"2016","unstructured":"Thiemann, S., and Baum, L.G. (2016). Galectins and immune responses-just how do they do those things they do? Annu Rev Immunol 34, 243\u2013264.","journal-title":"Annu Rev Immunol"},{"key":"9176_CR68","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.1074\/jbc.272.10.6416","volume":"272","author":"T\u00fcreci","year":"1997","unstructured":"T\u00fcreci, \u00d6., Schmitt, H., Fadle, N., Pfreundschuh, M., and Sahin, U. (1997). Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin\u2019s disease. J Biol Chem 272, 6416\u20136422.","journal-title":"J Biol Chem"},{"key":"9176_CR69","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1172\/JCI119429","volume":"99","author":"J. Wada","year":"1997","unstructured":"Wada, J., Ota, K., Kumar, A., Wallner, E.I., and Kanwar, Y.S. (1997). Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin.. J Clin Invest 99, 2452\u20132461.","journal-title":"J Clin Invest"},{"key":"9176_CR70","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"E.J. Wherry","year":"2011","unstructured":"Wherry, E.J. (2011). T cell exhaustion. Nat Immunol 12, 492\u2013499.","journal-title":"Nat Immunol"},{"key":"9176_CR71","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","volume":"41","author":"S.R. Woo","year":"2014","unstructured":"Woo, S.R., Fuertes, M.B., Corrales, L., Spranger, S., Furdyna, M.J., Leung, M.Y.K., Duggan, R., Wang, Y., Barber, G.N., Fitzgerald, K.A., Alegre, M.L., and Gajewski, T.F. (2014). STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity 41, 830\u2013842.","journal-title":"Immunity"},{"key":"9176_CR72","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.immuni.2014.06.011","volume":"41","author":"C. Wu","year":"2014","unstructured":"Wu, C., Thalhamer, T., Franca, R.F., Xiao, S., Wang, C., Hotta, C., Zhu, C., Hirashima, M., Anderson, A.C., and Kuchroo, V.K. (2014). Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells. Immunity 41, 270\u2013282.","journal-title":"Immunity"},{"key":"9176_CR73","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.4049\/jimmunol.180.7.4409","volume":"180","author":"L. Yang","year":"2008","unstructured":"Yang, L., Anderson, D.E., Kuchroo, J., and Hafler, D.A. (2008). Lack of TIM-3 immunoregulation in multiple sclerosis. J Immunol 180, 4409\u20134414.","journal-title":"J Immunol"},{"key":"9176_CR74","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1017\/S1462399408000719","volume":"10","author":"R.Y. Yang","year":"2008","unstructured":"Yang, R.Y., Rabinovich, G.A., and Liu, F.T. (2008). Galectins: structure, function and therapeutic potential. Expert Rev Mol Med 10, e17.","journal-title":"Expert Rev Mol Med"},{"key":"9176_CR75","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","volume":"375","author":"J.M. Zaretsky","year":"2016","unstructured":"Zaretsky, J.M., Garcia-Diaz, A., Shin, D.S., Escuin-Ordinas, H., Hugo, W., Hu-Lieskovan, S., Torrejon, D.Y., Abril-Rodriguez, G., Sandoval, S., Barthly, L., Saco, J., Homet Moreno, B., Mezzadra, R., Chmielowski, B., Ruchalski, K., Shintaku, I.P., Sanchez, P.J., Puig-Saus, C., Cherry, G., Seja, E., Kong, X., Pang, J., Berent-Maoz, B., Comin-Anduix, B., Graeber, T.G., Tumeh, P.C., Schumacher, T.N.M., Lo, R.S., and Ribas, A. (2016). Mutations associated with acquired resistance to PD-1 blockade in melanoma. N Engl J Med 375, 819\u2013829.","journal-title":"N Engl J Med"},{"key":"9176_CR76","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1182\/blood-2010-10-310425","volume":"117","author":"Q. Zhou","year":"2011","unstructured":"Zhou, Q., Munger, M.E., Veenstra, R.G., Weigel, B.J., Hirashima, M., Munn, D.H., Murphy, W.J., Azuma, M., Anderson, A.C., Kuchroo, V.K., and Blazar, B.R. (2011). Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia. Blood 117, 4501\u20134510.","journal-title":"Blood"},{"key":"9176_CR77","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni1271","volume":"6","author":"C. Zhu","year":"2005","unstructured":"Zhu, C., Anderson, A.C., Schubart, A., Xiong, H., Imitola, J., Khoury, S.J., Zheng, X.X., Strom, T.B., and Kuchroo, V.K. (2005). The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6, 1245\u20131252.","journal-title":"Nat Immunol"},{"key":"9176_CR78","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nri3845","volume":"15","author":"L. Zitvogel","year":"2015","unstructured":"Zitvogel, L., Galluzzi, L., Kepp, O., Smyth, M.J., and Kroemer, G. (2015). Type I interferons in anticancer immunity. Nat Rev Immunol 15, 405\u2013414.","journal-title":"Nat Rev Immunol"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11427-017-9176-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-017-9176-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-017-9176-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T01:53:37Z","timestamp":1516326817000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11427-017-9176-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":78,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["9176"],"URL":"https:\/\/doi.org\/10.1007\/s11427-017-9176-7","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}